Vasantika S.
@vsuryaw.bsky.social
Genomics | Genetics | Bioinformatics
Computational Scientist
Computational Scientist
Reposted by Vasantika S.
Logical #CARTCells are reaching the clinical stage!
First patient dosed in EVEREST-2 phase 1 clinical trial.
Target solid tumors that express mesothelin AND have lost HLA-A*02 expression, hence protecting normal cells.
Smart.
www.biospace.com/article/rele...
First patient dosed in EVEREST-2 phase 1 clinical trial.
Target solid tumors that express mesothelin AND have lost HLA-A*02 expression, hence protecting normal cells.
Smart.
www.biospace.com/article/rele...
May 22, 2024 at 1:35 PM
Logical #CARTCells are reaching the clinical stage!
First patient dosed in EVEREST-2 phase 1 clinical trial.
Target solid tumors that express mesothelin AND have lost HLA-A*02 expression, hence protecting normal cells.
Smart.
www.biospace.com/article/rele...
First patient dosed in EVEREST-2 phase 1 clinical trial.
Target solid tumors that express mesothelin AND have lost HLA-A*02 expression, hence protecting normal cells.
Smart.
www.biospace.com/article/rele...